Publication Date:
1998-06-25
Description:
Containment of the acquired immunodeficiency syndrome (AIDS) epidemic will require an effective human immunodeficiency virus type 1 (HIV-1) vaccine. Accumulating evidence suggests that such a vaccine must efficiently elicit an HIV-1-specific cytotoxic T lymphocyte (CTL) response. Nonhuman primate models will continue to provide an important tool for assessing the extent of protective immunity induced by various immunization strategies. Although replication-competent AIDS viruses attenuated for pathogenicity by selective gene deletions have provided protective immunity in nonhuman primate models, the long-term safety of such vaccines in human populations is suspect. Inactivated virus and subunit vaccines have elicited neither CTLs nor antibodies capable of neutralizing a wide array of patient HIV-1 isolates. Considerable effort is now being focused on evaluating live vector-based vaccine and plasmid DNA vaccine approaches for preventing HIV-1 infection both in animal model and human studies. Our growing understanding of the biology of HIV-1 and immune responses to this virus will continue to suggest improved vaccination approaches for exploration.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Letvin, N L -- New York, N.Y. -- Science. 1998 Jun 19;280(5371):1875-80.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉The author is at Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA. nletvin@bidmc.harvard.edu〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/9632379" target="_blank"〉PubMed〈/a〉
Keywords:
*AIDS Vaccines/immunology
;
Animals
;
Disease Models, Animal
;
Genetic Vectors
;
HIV Infections/immunology/*prevention & control/therapy/virology
;
HIV-1/*immunology/physiology
;
Humans
;
T-Lymphocytes, Cytotoxic/immunology
;
Vaccines, Attenuated/immunology
;
Vaccines, DNA/immunology
;
Vaccines, Inactivated/immunology
;
Vaccines, Synthetic/immunology
;
Virus Replication
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
